President Trump signed a sweeping order that will reverse several Biden-era executive orders aimed at lowering drug prices.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug ...

(HealthDay News) — Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news ...

But actions the new president has taken in his first days on the job could hit Americans — particularly seniors — in the wallet.  On Tuesday, the first full day of his new term, Trump scrapped ...

Health programs were among the subjects of a flurry of executive orders signed by President Donald Trump soon after his inauguration.

Granules India reported a drop in third-quarter profit on Friday, hurt by pricing pressure in its key European market.

Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that would require price disclosures on advertisements for prescription drugs. The bill would ...

Trump dismissed the order as part of what he called Biden’s “unpopular, inflationary, illegal, and radical practices.” ...

Trump has promised to cut regulations, impose sweeping tariffs, overhaul energy policy and lower interest rates. But not all ...

For years, the cost of prescription medications has been a hot topic for many Americans, especially those living in ...